Skip to content

Observational Study to Assess the Effect of the Accu-Chek® SugarView app on Subjects with Type 2 Diabetes

An Observational Study to Assess the Effect of the Accu-Chek® SugarView app (based on app version 4.0.3) on Diabetes Empowerment of Subjects with Type 2 Diabetes Mellitus (BEAT Accu-Chek SugarView India Study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043130
Enrollment
100
Registered
2022-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Accu-Chek® SugarView app: Observational Study to Assess the Effect of the Accu-Chek® SugarView app (based on app version 4.0.3) on Diabetes Empowerment of Subjects with Type 2 Diabetes

Sponsors

Roche Diabetes Care India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject has provided his/her signed informed consent. 2. Subject is = 18 years of age 3. Subject is diagnosed with diabetes type 2 and currently on exercise, diet or single or dual agent anti-diabetic therapy (but not on insulin and anti-diabetic drug with an hypoglycemic risk profile such as sulfonylureas) 4. Need to be empowered for disease self-management 5. Willingness to adhere to the app - Never used a blood glucose meter for self-testing of blood glucose before (SMBG naive) 6. Subject must have and can use a smartphone, and should complete training on usage of the application installed in smartphone 7. Subjects who are able to read and write in English language 8. Willing to participate in the study and comply with study procedures 9. Provide study demographics such as age, education level, gender, therapy type and occupation 10. Experienced in using apps; and were currently using apps installed on their smartphones

Exclusion criteria

Exclusion criteria: 1. Subject is pregnant or breastfeeding 2. Subject has incarceration or vision impairment not correctable with glasses or contact lenses 3. Subject is diagnosed with any clinically significant condition (e.g. infectious disease, major organ system disease, such as gastroparesis or renal disease, psychosis or cognitive impairment), at investigator’s discretion 4. Subject does undergo chemotherapy or radiation therapy (self-reported) 5. Subject is related to the investigator or research staff 6. Subject is using any other mobile device to monitor glucose levels 7. Subject shares phones with other persons

Design outcomes

Primary

MeasureTime frame
To assess the impact of the Accu-Chek SugarView mobile application on diabetes empowerment measured by the DES-SF questionnaire.Timepoint: Visit 2,3,5 & 6

Secondary

MeasureTime frame
- DTSQ , Health literacy (HLQ) - Accu-Chek SugarView User Experience Questionnaire - Medication list (name of the drug, dosage, frequency)/therapy (including frequency and type of exercise/type diet) per subject and per population - BMI, blood pressure, self-reported diabetes related symptoms - Self-reported HbA1c - percentage of glucose readings in target range - plasma glucose measurements in the normal range In-app user parameter as well as individual subjects: - number of reached goals - number of tests done - number of invalid testing (fail safe error, error code) - chosen goal - number of measurements in each range - used smartphone type (vendor, model, model number, e.g. Samsung Galaxy S10 , model number found in the phone information) Timepoint: Visit 2,3,5 & 6

Countries

India

Contacts

Public ContactDr Laxman Jakkala

Roche Diabetes Care India Pvt.

varsha.khatry@roche.com912250457300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026